Apotex, Sandoz Inc. and Hi-Tech Pharmacal Co. Inc. pointed the three-judge panel to several prior art references disclosing that bimatoprost — such as Allergan's Latisse product — and similar compounds used to treat glaucoma could promote hair and eyelash growth, which would nix Allergan's patent protection...